134 related articles for article (PubMed ID: 2142244)
1. Response to toremifene (Fc-1157a) therapy in tamoxifen failed patients with breast cancer. Preliminary communication.
Ebbs SR; Roberts J; Baum M
J Steroid Biochem; 1990 Jun; 36(3):239. PubMed ID: 2142244
[TBL] [Abstract][Full Text] [Related]
2. Phase II clinical study of toremifene in patients with metastatic breast cancer. Preliminary communication.
Modig H; Borgström S; Nilsson I; Westman G
J Steroid Biochem; 1990 Jun; 36(3):235-6. PubMed ID: 2142242
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of toremifene in breast cancer patients. A phase II study.
Valavaara R; Pyrhönen S; Heikkinen M; Rissanen P; Blanco G; Nordman E; Taskinen P; Holsti LR; Hajba A
J Steroid Biochem; 1990 Jun; 36(3):229-31. PubMed ID: 2142240
[TBL] [Abstract][Full Text] [Related]
4. Treatment of advanced breast cancer with 20 mg toremifene, a phase II study. Preliminary communication.
Pyrhönen S; Valavaara R; Heikkinen M; Rissanen P; Blanco G; Nordman E; Holsti LR; Hajba A
J Steroid Biochem; 1990 Jun; 36(3):227-8. PubMed ID: 2142239
[TBL] [Abstract][Full Text] [Related]
5. Phase II trials with toremifene in advanced breast cancer: a review.
Valavaara R
Breast Cancer Res Treat; 1990 Aug; 16 Suppl():S31-5. PubMed ID: 2149283
[TBL] [Abstract][Full Text] [Related]
6. Effect of toremifene in breast cancer patients. Preliminary communication.
Hindy I; Juhos E; Szántó J; Számel I
J Steroid Biochem; 1990 Jun; 36(3):225-6. PubMed ID: 2142238
[TBL] [Abstract][Full Text] [Related]
7. [The results of a comparative clinical study of the antiestrogenic preparations toremifene and tamoxifen in locally advanced and disseminated breast cancer].
Konstantinova MM; Gershanovich MA
Vopr Onkol; 1990; 36(10):1182-6. PubMed ID: 2147527
[TBL] [Abstract][Full Text] [Related]
8. Phase II clinical study of high-dose toremifene in patients with advanced breast cancer.
Modig H; Borgström S; Nilsson I; Westman G
J Steroid Biochem; 1990 Jun; 36(3):237-8. PubMed ID: 2142243
[TBL] [Abstract][Full Text] [Related]
9. Toremifene, a new antiestrogenic compound in the treatment of metastatic mammary cancer. A phase II study.
Gundersen S
J Steroid Biochem; 1990 Jun; 36(3):233-4. PubMed ID: 2142241
[TBL] [Abstract][Full Text] [Related]
10. A new triphenylethylene compound, Fc-1157a. II. Antitumor effects.
Kangas L; Nieminen AL; Blanco G; Grönroos M; Kallio S; Karjalainen A; Perilä M; Södervall M; Toivola R
Cancer Chemother Pharmacol; 1986; 17(2):109-13. PubMed ID: 2941177
[TBL] [Abstract][Full Text] [Related]
11. Toremifene, a new antiestrogenic compound, for treatment of advanced breast cancer. Phase II study.
Valavaara R; Pyrhönen S; Heikkinen M; Rissanen P; Blanco G; Thölix E; Nordman E; Taskinen P; Holsti L; Hajba A
Eur J Cancer Clin Oncol; 1988 Apr; 24(4):785-90. PubMed ID: 2968265
[TBL] [Abstract][Full Text] [Related]
12. High dose toremifene (240 mg daily) is effective as first line hormonal treatment in advanced breast cancer. An ongoing phase II multicenter Finnish-Latvian cooperative study.
Hietanen T; Baltina D; Johansson R; Numminen S; Hakala T; Helle L; Valavaara R
Breast Cancer Res Treat; 1990 Aug; 16 Suppl():S37-40. PubMed ID: 2149284
[TBL] [Abstract][Full Text] [Related]
13. A phase II study of toremifene in carcinoma corporis uteri. Preliminary communication.
Horváth G; Tropé C; Almbo HE
J Steroid Biochem; 1990 Jun; 36(3):241. PubMed ID: 2142245
[TBL] [Abstract][Full Text] [Related]
14. Phase III studies of toremifene in metastatic breast cancer.
Pyrhönen SO
Breast Cancer Res Treat; 1990 Aug; 16 Suppl():S41-6. PubMed ID: 2149285
[TBL] [Abstract][Full Text] [Related]
15. Antiestrogenic treatment of advanced and recurrent carcinoma corporis uteri--a phase II study of toremifene.
Horvath G; Stendahl U; Kalling M; Fernö M; Himmelmann A; Hajba A
Anticancer Res; 1990; 10(2A):323-5. PubMed ID: 2140668
[TBL] [Abstract][Full Text] [Related]
16. Comparison of toremifene and tamoxifen in post-menopausal patients with advanced breast cancer: a randomized double-blind, the 'nordic' phase III study.
Pyrhönen S; Valavaara R; Modig H; Pawlicki M; Pienkowski T; Gundersen S; Bauer J; Westman G; Lundgren S; Blanco G; Mella O; Nilsson I; Hietanen T; Hindy I; Vuorinen J; Hajba A
Br J Cancer; 1997; 76(2):270-7. PubMed ID: 9231932
[TBL] [Abstract][Full Text] [Related]
17. A phase I trial of toremifene, a new antiestrogen.
Hamm JT
Cancer Invest; 1990; 8(2):273-4. PubMed ID: 2144786
[No Abstract] [Full Text] [Related]
18. Phase II experience with toremifene in the treatment of ER-positive breast cancer of postmenopausal women.
Valavaara R
Cancer Invest; 1990; 8(2):275-6. PubMed ID: 2144787
[No Abstract] [Full Text] [Related]
19. Alternate antiestrogens and approaches to the prevention of breast cancer.
Jordan VC
J Cell Biochem Suppl; 1995; 22():51-7. PubMed ID: 8538210
[TBL] [Abstract][Full Text] [Related]
20. The significance of estrogen receptors in tamoxifen and toremifene therapy.
Valavaara R; Kangas L
Ann Clin Res; 1988; 20(5):380-8. PubMed ID: 2975479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
